Statement of NeedCardiovascular and peripheral arterial disease are causing a worldwide epidemic. Globally, coronary Artery Disease (CAD) accounts for approximately 18 million annual deaths. In the United States it causes over 600,000 annual deaths and is the leading cause of mortality. Structural Heart Disease increases both morbidity and mortality in the elderly population. One in eight people aged 75 or older have moderate or severe aortic stenosis and one in ten have moderate or severe mitral regurgitation in the United States. Although rheumatic valve disease remains the most prevalent form world-wide, global deaths from degenerative valvular heart disease have been steadily rising in the last 20 years. Peripheral Arterial Disease (PAD) affects 155 million people worldwide. In 2015 it was responsible for over 52,500 deaths up from 16,000 deaths in 1990. It carries a greater than 20% risk of a cardiovascular event in 10 years and a 5-year mortality rate of 30%. The New York Coronary and Vascular Summit (NYCVS) is organized jointly with Stony Brook University School of Medicine and Tulane School of Medicine, Divisions of Cardiology. This year it has also partnered with faculty from the Icahn School of Medicine at the Mount Sinai Hospital. Guest faculty includes national and international thought leaders in the field of Interventional Cardiology, Vascular Surgery and Interventional Radiology. This activity is accredited by Albert Einstein College of Medicine-Montefiore Medical Center.
Activity Goals and OverviewThe primary focus of this course is to present a multidisciplinary approach to the treatment of patients with complex coronary, peripheral vascular and structural heart disease. There will be an emphasis on presentation of live cases that will illustrate the state-of-the-art techniques for invasive therapy. Live cases will be combined with didactic presentations and discussion by expert faculty that will review emerging problems, appropriateness of revascularization and evidence-based practice guidelines.
Specific topics will include:
Coronary Artery Disease
- Treatment of calcified lesions
- Indications for mechanical circulatory support devices
- Chronic Total Occlusion/Left Main Stenting
- Evaluation for Micro-vascular Disease
Peripheral Arterial Disease
- Treatment of critical limb ischemia
- Novel access for complex interventions
- Non-invasive treatment of Aortic disease (endografts etc.)
- Drug eluting technologies (balloons and stents)
Valvular Heart Disease
- Long term data for TAVR
- Emerging treatment for the mitral valve
- Emerging treatment for the tricuspid valve
- Surgical treatment of valves in 2023 and beyond
Learning ObjectivesAfter attending this activity, participants will be able to:
- Select the appropriate revascularization strategy in the treatment of unprotected left main disease.
- Plan for the best interventional strategy for revascularization of chronic total occlusion.
- Apply case selection and choose the appropriate interventional devices for CAD, Structural Heart Disease and PAD treatment.
- Choose the appropriate mechanical support device in high risk coronary interventions
- Describe the new technology, devices and approaches in the carotid stenting.
- Discuss imaging approaches in CAD, Structural Heart Disease and PAD.
Intended AudienceThis activity is specifically designed for:
- Interventional cardiologists who manage patients with complex coronary and vascular lesions for revascularization
- Heart failure interventionist
- Interventional radiologists and vascular surgeons
- Cardiology fellows with an interest in Interventional Radiology and Endovascular Interventions
- Nurses, technicians, and other allied health care professionals who work in Cardiac Catheterization and Vascular Laboratories
AccreditationIn support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for a maximum of 7.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of CertificationSuccessful completion of this CME activity, which includes participation in the valuation component, enables the participant to earn up to 7.5 ABIM-Part II Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Special Needs (ADA)Albert Einstein College of Medicine-Montefiore Medical Center fully complies with the legal requirements of the Americans with Disabilities Act. If any participant needs special accommodations, please submit a written request at least two weeks prior to the activity to Center for Continuing Professional Development, firstname.lastname@example.org.
Cancellation PolicyRequest for refunds MUST be received in writing by September 22, 2023 and will be subject to an administration fee of $25.00. NO REFUNDS WILL BE MADE AFTER THIS DATE.
Financial Disclosure Statement
The “Policy on Identification, Mitigation and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that any individual in control of content, including faculty, participating in CME/ CE activities disclose to the audience all relevant financial relationships with ineligible companies* in the past 24 months. Any individual in control of content who refuses to disclose, or whose disclosed relationships prove to create a conflict of interest, will be recused. Individuals with the absence of relevant financial relationships with ineligible companies will be disclosed to the audience
All financial relationships of individuals in a position to control the content of this CME/ CE activity are identified and mitigated prior to the educational activity
*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients
For Further Information ContactCENTER FOR CONTINUING PROFESSIONAL DEVELOPMENT Call us at 718-920-6674 Email email@example.com
1440 Canal Street
New Orleans, LA 70112
1st Floor Auditorium